Lie Ping Chen

Normunity, Inc. is a biotechnology company that creates precision immuno-oncology medicines called immune normalizers. The company is based in West Haven, CT and has subsidiaries in the United States. These medicines target novel mechanisms that free the body's normal immunity against cancer. Normunity is based on an ongoing academic-biotech partnership with the lab of Dr. Lieping Chen at Yale School of Medicine. The company is advancing an emerging pipeline of immune normalizers, including initial drug programs that target mechanisms that drive the exclusion of T-cells from immune-sensitive tumors and other mechanisms that are barriers to normal immune function in cancer. The CEO of the company is Rachel W. Humphrey.

Mayo Clinic provides health care services. Its products and services include healthy living program, sports medicine, Mayo clinic health letter, medical products, population health and wellness programs, medical laboratory services and mayo clinic voice apps. The firm offers medical services in the areas of dermatology, allergy, hypertension, neurology, oncology, psychiatry, radiation oncology, and rheumatology. The company was founded by William J. Mayo and Charles H. Mayo in 1986 and is headquartered in Rochester, MN.

Amplimmune, Inc. develops immune-based biological treatment for cancer and autoimmune diseases. The company was founded by Michael Richman, Charles G. Drake, Andrea Cox, Drew M. Pardoll, Jonathan D. Powell, Lieping Chen, David S. Kabakoff, and Elizabeth Jaffee in 2007 and is headquartered in Gaithersburg, MD.